Portfolio company
Pi-Cardia
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-implant catheter devices that modify heart valve leaflets to treat calcification and facilitate valve replacement procedures for cardiac patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
TRiCares
This company develops a catheter-based tricuspid valve replacement system for patients suffering from tricuspid regurgitation.
Capstan Medical
This company develops robotic catheter platforms and implants to treat mitral and tricuspid valve disease for patients requiring heart valve repair or replacement.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
CardioMech AS
This company develops catheter-based artificial chords to repair mitral valves for patients suffering from degenerative mitral regurgitation.
